Cargando…

Severe myoclonic epilepsy of infancy: Seizure reduction during adjunctive eslicarbazepine in two cases()

OBJECTIVE: The aim of this study was to preliminarily determine, in a short open study, the effectiveness of eslicarbazepine acetate (ESL) in two patients with severe myoclonic epilepsy of infancy (SMEI). METHODS: We report on a 17-year-old Italian boy and a 21-year-old Italian girl with SMEI and a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buoni, Sabrina, Geronzi, Ursula, Orsi, Alessandra, Hayek, Youssef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501557/ https://www.ncbi.nlm.nih.gov/pubmed/26236634 http://dx.doi.org/10.1016/j.ebcr.2015.06.002

Ejemplares similares

Psychomotor development and seizure features in idiopathic myoclonic epilepsy in infancy
por: Jiang, Yongning, et al.
Publicado: (2022)

Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy
por: Auvin, Stéphane
Publicado: (2007)

A Review of Eslicarbazepine Acetate for the Adjunctive Treatment of Partial-Onset Epilepsy
por: Singh, Rajinder P., et al.
Publicado: (2011)

Paradoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsy
por: Makke, Yamane, et al.
Publicado: (2015)

Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures
por: Brown, Martin E, et al.
Publicado: (2010)

Juvenile Myoclonic Epilepsy: Seizure and Social Outcomes in Taiwan
por: Lim, Siew-Na, et al.
Publicado: (2023)

Severe myoclonic epilepsy of infancy (Dravet syndrome): Clinical and genetic features of nine Turkish patients
por: Özmen, Meral, et al.
Publicado: (2011)

Adjunctive Treatment With Eslicarbazepine Acetate for Adults and Children With Focal-Onset Epilepsy: A Meta-Analysis
por: Fei, Yanqing, et al.
Publicado: (2022)

Safety, Tolerability and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy in Patients Aged ≥ 65 Years with Focal Seizures
por: Costa, Raquel, et al.
Publicado: (2018)

Safety and Tolerability of Adjunctive Eslicarbazepine Acetate in Pediatric Patients (Aged 4-17 Years) With Focal Seizures
por: Mintz, Mark, et al.
Publicado: (2019)

Eslicarbazepine‐induced severe hyponatremia resulted in generalized tonic‐clonic seizure
por: Habib, Mhd Baraa, et al.
Publicado: (2021)

Intractable myoclonic seizures in an allogeneic stem cell transplant recipient: A rare case of myoclonic epilepsy
por: Robuccio, Anna, et al.
Publicado: (2015)

A Case of Dissociative Seizures Presented like Myoclonic Epilepsy
por: REDDY, Balaswamy, et al.
Publicado: (2018)

Eslicarbazepine Acetate as Adjunctive Therapy for Primary Generalized Tonic-Clonic Seizures in Adults: A Prospective Observational Study
por: Winter, Yaroslav, et al.
Publicado: (2022)

Eslicarbazepine acetate as adjunctive therapy in clinical practice: ESLADOBA study
por: Chaves, J., et al.
Publicado: (2017)

Sustained seizure remission on perampanel in progressive myoclonic epilepsy (Lafora disease)()
por: Schorlemmer, Kathrin, et al.
Publicado: (2013)

Adolescent-onset absence epilepsy years after resolution of childhood epilepsy with myoclonic-atonic seizures
por: Berth, Sarah H., et al.
Publicado: (2019)

Update on treatment of partial onset epilepsy: role of eslicarbazepine
por: Rauchenzauner, Markus, et al.
Publicado: (2010)

Absence Seizures as a Feature of Juvenile Myoclonic Epilepsy in Rhodesian Ridgeback Dogs
por: Wielaender, F., et al.
Publicado: (2017)

Incidence of seizure exacerbation and seizures reported as adverse events during adjunctive treatment with eslicarbazepine acetate: A pooled analysis of three Phase III controlled trials
por: Carreño, Mar, et al.
Publicado: (2017)

Epilepsy With Myoclonic Atonic Seizures: Why Is the Yield of Genetic Testing for a “Presumed Genetic” Epilepsy Low?
por: Nickels, Katherine
Publicado: (2020)

Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy
por: Sunkaraneni, Soujanya, et al.
Publicado: (2017)

Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies
por: Shorvon, S. D., et al.
Publicado: (2017)

Dibenzazepine Agents in Epilepsy: How Does Eslicarbazepine Acetate Differ?
por: Lawthom, Charlotte, et al.
Publicado: (2018)

Eslicarbazepine Acetate Modulates EEG Activity and Connectivity in Focal Epilepsy
por: Pellegrino, Giovanni, et al.
Publicado: (2018)

Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy
por: Tambucci, Renato, et al.
Publicado: (2016)

Functional Network Connectivity Patterns between Idiopathic Generalized Epilepsy with Myoclonic and Absence Seizures
por: Li, Qifu, et al.
Publicado: (2017)

Headache in juvenile myoclonic epilepsy
por: Schankin, Christoph J., et al.
Publicado: (2011)

Unaltered Network Activity and Interneuronal Firing During Spontaneous Cortical Dynamics In Vivo in a Mouse Model of Severe Myoclonic Epilepsy of Infancy
por: De Stasi, Angela Michela, et al.
Publicado: (2016)

Praxis-induced seizures in a patient with juvenile myoclonic epilepsy: MEG-EEG coregistration study
por: de León, Sira Carrasco-García, et al.
Publicado: (2015)

Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial
por: Sperling, Michael R, et al.
Publicado: (2015)

Insulinoma misdiagnosed as juvenile myoclonic epilepsy
por: Jaladyan, Varsine, et al.
Publicado: (2006)

Cognitive Impairment in Juvenile Myoclonic Epilepsy
por: Kim, Sun-Young, et al.
Publicado: (2007)

Progressive myoclonic epilepsy with Fanconi syndrome
por: Seaby, Eleanor G, et al.
Publicado: (2016)

Predictors of Outcome in Juvenile Myoclonic Epilepsy
por: Chen, Yiqian, et al.
Publicado: (2020)

Trait impulsivity in Juvenile Myoclonic Epilepsy
por: Shakeshaft, Amy, et al.
Publicado: (2020)

Personality disorders and Juvenil Myoclonic Epilepsy
por: Santos Carrasco, I., et al.
Publicado: (2022)

Late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A spectrum of progressive myoclonic epilepsy — Case report
por: Sharma, Chandra Mohan, et al.
Publicado: (2016)

Juvenile Myoclonic Epilepsy: Myoclonic Status Epilepticus without Coma - Report of Three Cases
por: Murthy, Jagarlapudi M. K.
Publicado: (2020)

YWHAG Mutations Cause Childhood Myoclonic Epilepsy and Febrile Seizures: Molecular Sub-regional Effect and Mechanism
por: Ye, Xing-Guang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_udp07ouslkj837q9io4fqg9brt